ANI Pharmaceuticals Reports First Quarter 2020 Results and Appoints Interim CEO

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. LRCX
8. MRK
9. LVS
10. CSX

Go back to ANI Pharmaceuticals Reports First Quarter 2020 Results and Appoints Interim CEO

ANI Pharma (ANIP) Tops Q1 EPS by 15c; Suspends FY20 Guidance

May 7, 2020 8:35 AM EDT

ANI Pharma (NASDAQ: ANIP) reported Q1 EPS of $1.04, $0.15 better than the analyst estimate of $0.89. Revenue for the quarter came in at $49.8 million versus the consensus estimate of $50.23 million.

For the first quarter 2020, ANI reports:

Net revenues of $49.8 million versus $52.9 million in 2019GAAP net loss of $7.0 million and diluted GAAP loss per share of $0.59Adjusted non-GAAP EBITDA of $17.6 millionAdjusted non-GAAP diluted earnings per share of $1.04

Arthur S. Przybyl, President and CEO,... More